Wealth Architects, LLC Bristol Myers Squibb CO Transaction History

Wealth Architects, LLC

$739 Million
Q1 2024

A detailed history of Wealth Architects, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wealth Architects, LLC holds 6,377 shares of BMY stock, worth $252,911. This represents 0.05% of its overall portfolio holdings.

Number of Shares

6,377

Previous 6,565 2.86%

Holding current value

$252,911

Previous $336,000 2.68%

% of portfolio

0.05%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $9,020 - $10,227	-188 Reduced 2.86%	6,377 $345,000
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $83,482 - $99,617	-1,722 Reduced 20.78%	6,565 $336,000
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $15,919 - $17,800	275 Added 3.43%	8,287 $480,000
Q2 2023 Aug 02, 2023	BUY	$63.71 - $70.74 $23,317 - $25,890	366 Added 4.79%	8,012 $512,000
Q1 2023 Apr 21, 2023	BUY	$65.71 - $74.53 $15,310 - $17,365	233 Added 3.14%	7,646 $529,000

Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $1,301 - $1,540	19 Added 0.26%	7,413 $533,000
Q3 2022 Oct 24, 2022	SELL	$0.13 - $76.84 $114 - $67,696	-881 Reduced 10.65%	7,394 $526,000
Q2 2022 Jul 29, 2022	BUY	$72.62 - $79.98 $17,791 - $19,595	245 Added 3.05%	8,275 $637,000
Q1 2022 May 17, 2022	SELL	$61.48 - $73.72 $22,993 - $27,571	-374 Reduced 4.45%	8,030 $586,000
Q4 2021 Jan 19, 2022	SELL	$53.63 - $62.52 $33,626 - $39,200	-627 Reduced 6.94%	8,404 $524,000
Q3 2021 Nov 09, 2021	BUY	$59.17 - $69.31 $23,312 - $27,308	394 Added 4.56%	9,031 $534,000
Q2 2021 Aug 09, 2021	BUY	$61.91 - $67.42 $37,765 - $41,126	610 Added 7.6%	8,637 $577,000
Q1 2021 Apr 29, 2021	BUY	$59.34 - $66.74 $14,004 - $15,750	236 Added 3.03%	8,027 $507,000
Q4 2020 Jan 28, 2021	BUY	$57.74 - $65.43 $18,188 - $20,610	315 Added 4.21%	7,791 $483,000
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $3,675 - $4,072	64 Added 0.86%	7,476 $451,000
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $219 - $256	-4 Reduced 0.05%	7,412 $436,000
Q1 2020 Apr 23, 2020	BUY	$46.4 - $67.43 $25,148 - $36,547	542 Added 7.88%	7,416 $413,000
Q4 2019 Jan 28, 2020	BUY	$49.21 - $64.19 $5,363 - $6,996	109 Added 1.61%	6,874 $441,000
Q3 2019 Oct 23, 2019	BUY	$42.77 - $50.71 $3,635 - $4,310	85 Added 1.27%	6,765 $343,000
Q2 2019 Jul 12, 2019	BUY	$44.62 - $49.34 $17,580 - $19,439	394 Added 6.27%	6,680 $303,000
Q1 2019 May 01, 2019	BUY	$45.12 - $53.8 $7,986 - $9,522	177 Added 2.9%	6,286 $300,000
Q4 2018 Jan 17, 2019	SELL	$48.76 - $63.23 $39,690 - $51,469	-814 Reduced 11.76%	6,109 $318,000
Q3 2018 Oct 04, 2018	BUY	$55.19 - $62.25 $46,801 - $52,788	848 Added 13.96%	6,923 $430,000
Q2 2018 Jul 19, 2018	SELL	$50.53 - $62.98 $3,688 - $4,597	-73 Reduced 1.19%	6,075 $336,000
Q4 2017 Jan 31, 2018	SELL	$59.94 - $65.35 $16,663 - $18,167	-278 Reduced 4.33%	6,148 $377,000
Q3 2017 Nov 08, 2017	SELL	$55.23 - $63.74 $8,892 - $10,262	-161 Reduced 2.44%	6,426 $410,000
Q2 2017 Aug 10, 2017	BUY	N/A	6,587	6,587 $367,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $84.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Architects, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Architects, LLC with notifications on news.

Account

Wealth Architects, LLC Bristol Myers Squibb CO Transaction History